Skip to main content
Top
Published in: Pain and Therapy 2/2020

Open Access 01-12-2020 | Mood Disorders | Review

The Physiology and Maintenance of Respiration: A Narrative Review

Authors: Lynn R. Webster, Suzanne Karan

Published in: Pain and Therapy | Issue 2/2020

Login to get access

Abstract

Chronic pain is one of the most common reasons adults seek medical care and is often managed with opioid analgesics; however, opioids may cause respiratory depression by suppressing various components of respiration. Respiration is the physiological process that facilitates gas exchange and is mediated through the proper function of and communication among central neural control (respiratory drive), sensory input systems, the lungs, and the muscles involved in respiration. Normal respiratory function can be dampened with the use of central nervous system (CNS) depressants and/or underlying health conditions. Patients with chronic pain are often exposed to CNS depressants other than opioids, including benzodiazepines, barbiturates, nonbenzodiazepine sedative-hypnotics, and ethanol, which can function synergistically with opioids to increase the risk of respiratory depression. Some patients may also have underlying health issues, such as obstructive sleep apnea, that can be exacerbated with the use of opioids and other CNS depressants and further contribute to respiratory depression. Clinicians should have a thorough understanding of respiration, recognize how various CNS depressants suppress it, and take necessary steps to mitigate the risk of opioid-induced respiratory depression by collaborating with a multidisciplinary team (i.e., sleep and pain specialists), choosing appropriate medications, and educating patients on the proper use and storage of opioids.
Literature
1.
go back to reference Rosenquist R. Use of opioids in the management of chronic non-cancer pain. In: Aaronson M, Fishman S, Crowley M, editors. UpToDate. Waltham: UptoDate; 2020. Rosenquist R. Use of opioids in the management of chronic non-cancer pain. In: Aaronson M, Fishman S, Crowley M, editors. UpToDate. Waltham: UptoDate; 2020.
2.
go back to reference Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–6.PubMedPubMedCentral Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–6.PubMedPubMedCentral
4.
go back to reference Dahan A, van der Schrier R, Smith T, Aarts L, van Velzen M, Niesters M. Averting opioid-induced respiratory depression without affecting analgesia. Anesthesiology. 2018;128(5):1027–37.PubMed Dahan A, van der Schrier R, Smith T, Aarts L, van Velzen M, Niesters M. Averting opioid-induced respiratory depression without affecting analgesia. Anesthesiology. 2018;128(5):1027–37.PubMed
5.
go back to reference Volkow ND, McLellan AT. Opioid abuse in chronic pain—misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253–63.PubMed Volkow ND, McLellan AT. Opioid abuse in chronic pain—misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253–63.PubMed
7.
go back to reference Jonkman AH, de Vries HJ, Heunks LMA. Physiology of the respiratory drive in ICU patients: implications for diagnosis and treatment. Crit Care. 2020;24(1):104.PubMedPubMedCentral Jonkman AH, de Vries HJ, Heunks LMA. Physiology of the respiratory drive in ICU patients: implications for diagnosis and treatment. Crit Care. 2020;24(1):104.PubMedPubMedCentral
9.
go back to reference Montandon G, Slutsky AS. Solving the opioid crisis: respiratory depression by opioids as critical end point. Chest. 2019;156(4):653–8.PubMed Montandon G, Slutsky AS. Solving the opioid crisis: respiratory depression by opioids as critical end point. Chest. 2019;156(4):653–8.PubMed
10.
go back to reference Schiller EY, Mechanic OJ. Opioid overdose. Treasure Island: StatPearls; 2020. Schiller EY, Mechanic OJ. Opioid overdose. Treasure Island: StatPearls; 2020.
11.
go back to reference Brinkman JE, Sharma S. Physiology, respiratory drive. Treasure Island: StatPearls; 2020. Brinkman JE, Sharma S. Physiology, respiratory drive. Treasure Island: StatPearls; 2020.
12.
go back to reference Cloutier M. Control of respiration. In: Respiratory physiology. 2nd ed. Amsterdam: Elsevier; 2018. Cloutier M. Control of respiration. In: Respiratory physiology. 2nd ed. Amsterdam: Elsevier; 2018.
13.
go back to reference West JB, Luks AM. West's respiratory physiology: the essentials. 10th ed. Philadelphia: Wolters Kluwer; 2016. West JB, Luks AM. West's respiratory physiology: the essentials. 10th ed. Philadelphia: Wolters Kluwer; 2016.
14.
go back to reference Johnson D. Disorders of ventilatory control. In: Manaker S, Hollingsworth H, Eichler A, editors. UpToDate. Waltham: UptoDate; 2020. Johnson D. Disorders of ventilatory control. In: Manaker S, Hollingsworth H, Eichler A, editors. UpToDate. Waltham: UptoDate; 2020.
15.
16.
go back to reference Dubois M, Chenivesse C, Raux M, et al. Neurophysiological evidence for a cortical contribution to the wakefulness-related drive to breathe explaining hypocapnia-resistant ventilation in humans. J Neurosci. 2016;36(41):10673–82.PubMedPubMedCentral Dubois M, Chenivesse C, Raux M, et al. Neurophysiological evidence for a cortical contribution to the wakefulness-related drive to breathe explaining hypocapnia-resistant ventilation in humans. J Neurosci. 2016;36(41):10673–82.PubMedPubMedCentral
17.
go back to reference Fink BR. Influence of cerebral activity in wakefulness on regulation of breathing. J Appl Physiol. 1961;16:15–20.PubMed Fink BR. Influence of cerebral activity in wakefulness on regulation of breathing. J Appl Physiol. 1961;16:15–20.PubMed
18.
go back to reference Lumb, A. Control of breathing. In: Nunn’s applied respiratory physiology. 8th ed. Amsterdam: Elsevier; 2016. Lumb, A. Control of breathing. In: Nunn’s applied respiratory physiology. 8th ed. Amsterdam: Elsevier; 2016.
19.
go back to reference Bolser DC, Pitts TE, Davenport PW, Morris KF. Role of the dorsal medulla in the neurogenesis of airway protection. Pulm Pharmacol Ther. 2015;35:105–10.PubMedPubMedCentral Bolser DC, Pitts TE, Davenport PW, Morris KF. Role of the dorsal medulla in the neurogenesis of airway protection. Pulm Pharmacol Ther. 2015;35:105–10.PubMedPubMedCentral
20.
go back to reference Pagliardini S, Janczewski WA, Tan W, Dickson CT, Deisseroth K, Feldman JL. Active expiration induced by excitation of ventral medulla in adult anesthetized rats. J Neurosci. 2011;31(8):2895–905.PubMedPubMedCentral Pagliardini S, Janczewski WA, Tan W, Dickson CT, Deisseroth K, Feldman JL. Active expiration induced by excitation of ventral medulla in adult anesthetized rats. J Neurosci. 2011;31(8):2895–905.PubMedPubMedCentral
21.
go back to reference Moini J. Respiratory system. In: Moini J, editor. Anatomy and physiology for healthcare professionals. 3rd ed. Burlington: Jones and Bartlett Learning; 2020. p. 538–570. Moini J. Respiratory system. In: Moini J, editor. Anatomy and physiology for healthcare professionals. 3rd ed. Burlington: Jones and Bartlett Learning; 2020. p. 538–570.
22.
go back to reference Bonham AC. Neurotransmitters in the CNS control of breathing. Respir Physiol. 1995;101(3):219–30.PubMed Bonham AC. Neurotransmitters in the CNS control of breathing. Respir Physiol. 1995;101(3):219–30.PubMed
24.
go back to reference Daly M. Hypoventilation. In: Silverstein D, Ryan M, Hopper K, editors. Small animal critical care medicine. 2nd ed. Philadelphia: Saunders; 2014. p. 86–92. Daly M. Hypoventilation. In: Silverstein D, Ryan M, Hopper K, editors. Small animal critical care medicine. 2nd ed. Philadelphia: Saunders; 2014. p. 86–92.
25.
go back to reference Horn EM, Waldrop TG. Suprapontine control of respiration. Respir Physiol. 1998;114(3):201–11.PubMed Horn EM, Waldrop TG. Suprapontine control of respiration. Respir Physiol. 1998;114(3):201–11.PubMed
26.
go back to reference Betts J, Kelly A, Wise J. The process of breathing. In: Anatomy and physiology. Houston: OpenStax; 2013. Betts J, Kelly A, Wise J. The process of breathing. In: Anatomy and physiology. Houston: OpenStax; 2013.
27.
go back to reference Gourine A, Spyer K. Autonomic nervous system: central respiratory control. Encyclopedia of neuroscience; 2009. p. 883–890. Gourine A, Spyer K. Autonomic nervous system: central respiratory control. Encyclopedia of neuroscience; 2009. p. 883–890.
29.
go back to reference Vadhan J, Tadi P. Physiology, Herring Breuer reflex. Treasure Island: StatPearls; 2020. Vadhan J, Tadi P. Physiology, Herring Breuer reflex. Treasure Island: StatPearls; 2020.
30.
go back to reference Schwartzstein R. Dyspnea. In: Kasper D, Fauci A, Hauser S, editors. Harrison’s principles of internal medicine. 19th ed. New York: McGraw-Hill; 2015. Schwartzstein R. Dyspnea. In: Kasper D, Fauci A, Hauser S, editors. Harrison’s principles of internal medicine. 19th ed. New York: McGraw-Hill; 2015.
31.
go back to reference Johnson D. Control of ventilation. In: Flaherty K, Manaker S, Finlay G, editors. UpToDate. Waltham: UptoDate; 2020. Johnson D. Control of ventilation. In: Flaherty K, Manaker S, Finlay G, editors. UpToDate. Waltham: UptoDate; 2020.
32.
go back to reference Ward DS, Dahan A, Teppema LJ. Pharmacology and pathophysiology of the control of breathing. Boca Raton: Taylor and Francis; 2005. Ward DS, Dahan A, Teppema LJ. Pharmacology and pathophysiology of the control of breathing. Boca Raton: Taylor and Francis; 2005.
33.
go back to reference Guyenet PG, Stornetta RL, Bayliss DA. Retrotrapezoid nucleus and central chemoreception. J Physiol. 2008;586(8):2043–8.PubMedPubMedCentral Guyenet PG, Stornetta RL, Bayliss DA. Retrotrapezoid nucleus and central chemoreception. J Physiol. 2008;586(8):2043–8.PubMedPubMedCentral
34.
go back to reference Molkov YI, Bacak BJ, Dick TE, Rybak IA. Control of breathing by interacting pontine and pulmonary feedback loops. Front Neural Circuits. 2013;7:16.PubMedPubMedCentral Molkov YI, Bacak BJ, Dick TE, Rybak IA. Control of breathing by interacting pontine and pulmonary feedback loops. Front Neural Circuits. 2013;7:16.PubMedPubMedCentral
35.
go back to reference Katz E. Disorders of central respiratory control during sleep in children. In: Therapy in sleep medicine. 1st ed. Philadelphia: Elsevier; 2011. Katz E. Disorders of central respiratory control during sleep in children. In: Therapy in sleep medicine. 1st ed. Philadelphia: Elsevier; 2011.
36.
go back to reference Tamul P, Ault M. Respiratory function in anesthesia. In: Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, Ortega R, editors. Clinical anesthesia. 8th ed. Philadelphia: Lippincott Williams and Wilkins; 2017. Tamul P, Ault M. Respiratory function in anesthesia. In: Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, Ortega R, editors. Clinical anesthesia. 8th ed. Philadelphia: Lippincott Williams and Wilkins; 2017.
37.
38.
go back to reference Schwartz AR, Smith PL. CrossTalk proposal: the human upper airway does behave like a Starling resistor during sleep. J Physiol. 2013;591(9):2229–32.PubMedPubMedCentral Schwartz AR, Smith PL. CrossTalk proposal: the human upper airway does behave like a Starling resistor during sleep. J Physiol. 2013;591(9):2229–32.PubMedPubMedCentral
39.
go back to reference Series F, Cormier Y, Desmeules M. Influence of passive changes of lung volume on upper airways. J Appl Physiol. 1990;68(5):2159–64.PubMed Series F, Cormier Y, Desmeules M. Influence of passive changes of lung volume on upper airways. J Appl Physiol. 1990;68(5):2159–64.PubMed
40.
go back to reference Betts J, Kelly A, Wise J. Modifications in respiratory functions. In: Anatomy and physiology. Houston: OpenStax; 2013. Betts J, Kelly A, Wise J. Modifications in respiratory functions. In: Anatomy and physiology. Houston: OpenStax; 2013.
41.
go back to reference Hall JE. Respiration. In: Guyton and Hall textbook of medical physiology. 13th ed. Philadelphia: Elsevier; 2015. p. 497–557. Hall JE. Respiration. In: Guyton and Hall textbook of medical physiology. 13th ed. Philadelphia: Elsevier; 2015. p. 497–557.
43.
go back to reference Hallett S, Toro F, Ashurst JV. Physiology, tidal volume. Treasure Island: StatPearls; 2020. Hallett S, Toro F, Ashurst JV. Physiology, tidal volume. Treasure Island: StatPearls; 2020.
44.
go back to reference Hirshman CA, McCullough RE, Weil JV. Normal values for hypoxic and hypercapnic ventilatory drives in man. J Appl Physiol. 1975;38(6):1095–8.PubMed Hirshman CA, McCullough RE, Weil JV. Normal values for hypoxic and hypercapnic ventilatory drives in man. J Appl Physiol. 1975;38(6):1095–8.PubMed
45.
go back to reference Feller-Kopman DJ, Schwartzstein RM. Mechanisms, causes, and effects of hypercapnia. In: Stoller J, Finlay G, editors. UpToDate. Waltham: UptoDate; 2020. Feller-Kopman DJ, Schwartzstein RM. Mechanisms, causes, and effects of hypercapnia. In: Stoller J, Finlay G, editors. UpToDate. Waltham: UptoDate; 2020.
46.
go back to reference Benner A, Sharma S. Physiology, carbon dioxide response curve. Treasure Island: StatPearls; 2020. Benner A, Sharma S. Physiology, carbon dioxide response curve. Treasure Island: StatPearls; 2020.
48.
go back to reference Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A. Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012;18(37):5994–6004.PubMed Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A. Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012;18(37):5994–6004.PubMed
49.
go back to reference Vieweg WV, Lipps WF, Fernandez A. Opioids and methadone equivalents for clinicians. Prim Care Companion J Clin Psychiatry. 2005;7(3):86–8.PubMedPubMedCentral Vieweg WV, Lipps WF, Fernandez A. Opioids and methadone equivalents for clinicians. Prim Care Companion J Clin Psychiatry. 2005;7(3):86–8.PubMedPubMedCentral
50.
go back to reference Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008;100(6):747–58.PubMed Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008;100(6):747–58.PubMed
51.
go back to reference Pattinson KT, Governo RJ, MacIntosh BJ, et al. Opioids depress cortical centers responsible for the volitional control of respiration. J Neurosci. 2009;29(25):8177–86.PubMedPubMedCentral Pattinson KT, Governo RJ, MacIntosh BJ, et al. Opioids depress cortical centers responsible for the volitional control of respiration. J Neurosci. 2009;29(25):8177–86.PubMedPubMedCentral
54.
go back to reference Suddock JT, Cain MD. Barbiturate toxicity. Treasure Island: StatPearls; 2020. Suddock JT, Cain MD. Barbiturate toxicity. Treasure Island: StatPearls; 2020.
55.
go back to reference Tobias JD, Leder M. Procedural sedation: a review of sedative agents, monitoring, and management of complications. Saudi J Anaesth. 2011;5(4):395–410.PubMedPubMedCentral Tobias JD, Leder M. Procedural sedation: a review of sedative agents, monitoring, and management of complications. Saudi J Anaesth. 2011;5(4):395–410.PubMedPubMedCentral
56.
go back to reference Bonnet MH, Arand DL. Behavioral and pharmacologic therapies for chronic insomnia in adults. In: Benca R, Eichler A, editors. UpToDate. Waltham: UptoDate; 2020. Bonnet MH, Arand DL. Behavioral and pharmacologic therapies for chronic insomnia in adults. In: Benca R, Eichler A, editors. UpToDate. Waltham: UptoDate; 2020.
57.
go back to reference Vozoris NT. Do benzodiazepines contribute to respiratory problems? Expert Rev Respir Med. 2014;8(6):661–3.PubMed Vozoris NT. Do benzodiazepines contribute to respiratory problems? Expert Rev Respir Med. 2014;8(6):661–3.PubMed
58.
go back to reference Kang M, Ghassemzadeh S. Benzodiazepine toxicity. Treasure Island: StatPearls; 2020. Kang M, Ghassemzadeh S. Benzodiazepine toxicity. Treasure Island: StatPearls; 2020.
59.
go back to reference Beaupre A, Soucy R, Phillips R, Bourgouin J. Respiratory center output following zopiclone or diazepam administration in patients with pulmonary disease. Respiration. 1988;54(4):235–40.PubMed Beaupre A, Soucy R, Phillips R, Bourgouin J. Respiratory center output following zopiclone or diazepam administration in patients with pulmonary disease. Respiration. 1988;54(4):235–40.PubMed
60.
go back to reference Chung WS, Lai CY, Lin CL, Kao CH. Adverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease: a population-based case-control study. Medicine (Baltimore). 2015;94(27):e1110. Chung WS, Lai CY, Lin CL, Kao CH. Adverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease: a population-based case-control study. Medicine (Baltimore). 2015;94(27):e1110.
61.
62.
go back to reference LaHood A, Kok S. Ethanol toxicity. Treasure Island: StatPearls; 2020. LaHood A, Kok S. Ethanol toxicity. Treasure Island: StatPearls; 2020.
64.
65.
go back to reference Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med. 2008;9(4):425–32.PubMed Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med. 2008;9(4):425–32.PubMed
66.
go back to reference Carberry JC, Fisher LP, Grunstein RR, et al. Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem. Eur Respir J. 2017;50(6):1701344.PubMed Carberry JC, Fisher LP, Grunstein RR, et al. Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem. Eur Respir J. 2017;50(6):1701344.PubMed
67.
go back to reference Dahan A, Yassen A, Bijl H, et al. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth. 2005;94(6):825–34.PubMed Dahan A, Yassen A, Bijl H, et al. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth. 2005;94(6):825–34.PubMed
68.
go back to reference Emery MA, Eitan S. Members of the same pharmacological family are not alike: different opioids, different consequences, hope for the opioid crisis? Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:428–49.PubMed Emery MA, Eitan S. Members of the same pharmacological family are not alike: different opioids, different consequences, hope for the opioid crisis? Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:428–49.PubMed
70.
go back to reference Dahan A, Yassen A, Romberg R, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96(5):627–32.PubMed Dahan A, Yassen A, Romberg R, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96(5):627–32.PubMed
71.
go back to reference van der Schrier R, Roozekrans M, van Velzen M, Dahan A, Niesters M. Opioid-induced respiratory depression: reversal by non-opioid drugs. F1000Prime Rep. 2014;6:79. van der Schrier R, Roozekrans M, van Velzen M, Dahan A, Niesters M. Opioid-induced respiratory depression: reversal by non-opioid drugs. F1000Prime Rep. 2014;6:79.
72.
go back to reference Durotram XR. Prescribing information. Chatswood: iNova Pharmaceuticals; 2019. Durotram XR. Prescribing information. Chatswood: iNova Pharmaceuticals; 2019.
73.
go back to reference Nucynta ER. Prescribing information. Stoughton: Collegium Pharmaceutical Inc.; 2019. Nucynta ER. Prescribing information. Stoughton: Collegium Pharmaceutical Inc.; 2019.
74.
go back to reference Gudin J, Fudin J. A narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain. Pain Ther. 2020;9(1):41–544.PubMedPubMedCentral Gudin J, Fudin J. A narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain. Pain Ther. 2020;9(1):41–544.PubMedPubMedCentral
75.
go back to reference Pedersen MF, Wrobel TM, Marcher-Rorsted E, et al. Biased agonism of clinically approved mu-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics. Neuropharmacology. 2020;166:107718.PubMed Pedersen MF, Wrobel TM, Marcher-Rorsted E, et al. Biased agonism of clinically approved mu-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics. Neuropharmacology. 2020;166:107718.PubMed
76.
go back to reference Davis MP, Pasternak G, Behm B. Treating chronic pain: an overview of clinical studies centered on the buprenorphine option. Drugs. 2018;78(12):1211–28.PubMedPubMedCentral Davis MP, Pasternak G, Behm B. Treating chronic pain: an overview of clinical studies centered on the buprenorphine option. Drugs. 2018;78(12):1211–28.PubMedPubMedCentral
77.
go back to reference Raffa RB, Haidery M, Huang HM, et al. The clinical analgesic efficacy of buprenorphine. J Clin Pharm Ther. 2014;39(6):577–83.PubMed Raffa RB, Haidery M, Huang HM, et al. The clinical analgesic efficacy of buprenorphine. J Clin Pharm Ther. 2014;39(6):577–83.PubMed
78.
go back to reference McPherson J, Rivero G, Baptist M, et al. mu-Opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization. Mol Pharmacol. 2010;78(4):756–66.PubMedPubMedCentral McPherson J, Rivero G, Baptist M, et al. mu-Opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization. Mol Pharmacol. 2010;78(4):756–66.PubMedPubMedCentral
79.
go back to reference Corder G, Castro DC, Bruchas MR, Scherrer G. Endogenous and exogenous opioids in pain. Annu Rev Neurosci. 2018;41:453–73.PubMedPubMedCentral Corder G, Castro DC, Bruchas MR, Scherrer G. Endogenous and exogenous opioids in pain. Annu Rev Neurosci. 2018;41:453–73.PubMedPubMedCentral
80.
go back to reference Tori ME, Larochelle MR, Naimi TS. Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999–2017. JAMA Netw Open. 2020;3(4):e202361.PubMedPubMedCentral Tori ME, Larochelle MR, Naimi TS. Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999–2017. JAMA Netw Open. 2020;3(4):e202361.PubMedPubMedCentral
81.
go back to reference Alexander CM, Seifert HA, Blouin RT, Conard PF, Gross JB. Diphenhydramine enhances the interaction of hypercapnic and hypoxic ventilatory drive. Anesthesiology. 1994;80(4):789–95.PubMed Alexander CM, Seifert HA, Blouin RT, Conard PF, Gross JB. Diphenhydramine enhances the interaction of hypercapnic and hypoxic ventilatory drive. Anesthesiology. 1994;80(4):789–95.PubMed
82.
go back to reference Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther. 2002;27(6):391–401.PubMed Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther. 2002;27(6):391–401.PubMed
83.
go back to reference Bilia AR, Gallon S, Vincieri FF. Kava-kava and anxiety: growing knowledge about the efficacy and safety. Life Sci. 2002;70(22):2581–97.PubMed Bilia AR, Gallon S, Vincieri FF. Kava-kava and anxiety: growing knowledge about the efficacy and safety. Life Sci. 2002;70(22):2581–97.PubMed
84.
go back to reference Kapalka G. Anxiety disorders. In: Nutritional and herbal therapies for children and adolescents a handbook for mental health clinicians practical resources for the mental health professional. San Diego: Academic; 2010. p. 219–58. Kapalka G. Anxiety disorders. In: Nutritional and herbal therapies for children and adolescents a handbook for mental health clinicians practical resources for the mental health professional. San Diego: Academic; 2010. p. 219–58.
86.
go back to reference Overbeek DL, Abraham J, Munzer BW. Kratom (mitragynine) ingestion requiring naloxone reversal. Clin Pract Cases Emerg Med. 2019;3(1):24–6.PubMedPubMedCentral Overbeek DL, Abraham J, Munzer BW. Kratom (mitragynine) ingestion requiring naloxone reversal. Clin Pract Cases Emerg Med. 2019;3(1):24–6.PubMedPubMedCentral
87.
go back to reference Hays SR. Inhalation anesthetic agents: clinical effects and uses. In: Joshi G, Nussmeier N, editors. UpToDate. Waltham: UptoDate; 2020. Hays SR. Inhalation anesthetic agents: clinical effects and uses. In: Joshi G, Nussmeier N, editors. UpToDate. Waltham: UptoDate; 2020.
88.
go back to reference van der Schrier R, Roozekrans M, Olofsen E, et al. Influence of ethanol on oxycodone-induced respiratory depression: a dose-escalating study in young and elderly individuals. Anesthesiology. 2017;126(3):534–42.PubMed van der Schrier R, Roozekrans M, Olofsen E, et al. Influence of ethanol on oxycodone-induced respiratory depression: a dose-escalating study in young and elderly individuals. Anesthesiology. 2017;126(3):534–42.PubMed
90.
go back to reference Horsfall JT, Sprague JE. The pharmacology and toxicology of the ‘Holy Trinity’. Basic Clin Pharmacol Toxicol. 2017;120(2):115–9.PubMed Horsfall JT, Sprague JE. The pharmacology and toxicology of the ‘Holy Trinity’. Basic Clin Pharmacol Toxicol. 2017;120(2):115–9.PubMed
91.
go back to reference Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. December 18, 2014. The DAWN report: benzodiazepines in combination with opioid pain relievers or alcohol: greater risk of more serious ED visit outcomes. Rockville: SAMHSA. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. December 18, 2014. The DAWN report: benzodiazepines in combination with opioid pain relievers or alcohol: greater risk of more serious ED visit outcomes. Rockville: SAMHSA.
92.
go back to reference Anwari JS, Iqbal S. Antihistamines and potentiation of opioid induced sedation and respiratory depression. Anaesthesia. 2003;58(5):494–5.PubMed Anwari JS, Iqbal S. Antihistamines and potentiation of opioid induced sedation and respiratory depression. Anaesthesia. 2003;58(5):494–5.PubMed
93.
go back to reference Goodman CW, Brett AS. Gabapentinoids for pain: potential unintended consequences. Am Fam Physician. 2019;100(11):672–5.PubMed Goodman CW, Brett AS. Gabapentinoids for pain: potential unintended consequences. Am Fam Physician. 2019;100(11):672–5.PubMed
95.
go back to reference Hughes SG. Prescribing for the elderly patient: why do we need to exercise caution? Br J Clin Pharmacol. 1998;46(6):531–3.PubMedPubMedCentral Hughes SG. Prescribing for the elderly patient: why do we need to exercise caution? Br J Clin Pharmacol. 1998;46(6):531–3.PubMedPubMedCentral
97.
go back to reference Chung F, Abdullah HR, Liao P. STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 2016;149(3):631–8.PubMed Chung F, Abdullah HR, Liao P. STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 2016;149(3):631–8.PubMed
98.
go back to reference Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108(5):812–21.PubMed Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108(5):812–21.PubMed
99.
go back to reference Collop N. Home sleep apnea testing for obstructive sleep apnea in adults. In: Harding S, Finlay G, editors. UpToDate. Waltham: UptoDate; 2020. Collop N. Home sleep apnea testing for obstructive sleep apnea in adults. In: Harding S, Finlay G, editors. UpToDate. Waltham: UptoDate; 2020.
100.
go back to reference Rosen IM, Aurora RN, Kirsch DB, et al. Chronic opioid therapy and sleep: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2019;15(11):1671–3.PubMedPubMedCentral Rosen IM, Aurora RN, Kirsch DB, et al. Chronic opioid therapy and sleep: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2019;15(11):1671–3.PubMedPubMedCentral
101.
go back to reference Theodore AC. Measures of oxygenation and mechanisms of hypoxemia. In: Parsons P, Finlay G, editors. UpToDate. Waltham: UptoDate; 2020. Theodore AC. Measures of oxygenation and mechanisms of hypoxemia. In: Parsons P, Finlay G, editors. UpToDate. Waltham: UptoDate; 2020.
102.
go back to reference Agrawal MB, Awad NT. Correlation between six minute walk test and spirometry in chronic pulmonary disease. J Clin Diagn Res. 2015;9(8):OC01–4.PubMedPubMedCentral Agrawal MB, Awad NT. Correlation between six minute walk test and spirometry in chronic pulmonary disease. J Clin Diagn Res. 2015;9(8):OC01–4.PubMedPubMedCentral
103.
go back to reference Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.PubMed Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.PubMed
Metadata
Title
The Physiology and Maintenance of Respiration: A Narrative Review
Authors
Lynn R. Webster
Suzanne Karan
Publication date
01-12-2020
Publisher
Springer Healthcare
Published in
Pain and Therapy / Issue 2/2020
Print ISSN: 2193-8237
Electronic ISSN: 2193-651X
DOI
https://doi.org/10.1007/s40122-020-00203-2

Other articles of this Issue 2/2020

Pain and Therapy 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.